Abeona Therapeutics Inc. Common Stock(ABEO)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

ABEO iron condor setups ABEO expected move ABEO IV rank history ABEO Fibonacci levels ABEO insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

ABEO $5.41 —
Snapshot
$5.41
52-Week Range
$4.00 – $7.65
YTD
+1.79%
IV Rank (30D)
85.0
Straddle Price
$1.50
P/C Vol Ratio
0.92
Market Cap
$0.3B
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.96%
Beta vs SPY1.27
Cost of Equity (CAPM)11.93% (VRP-adj)
WACC11.85%
Volatility Risk Premium+187.2pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.1B
Return on Equity (TTM)-49.1%
Book / Price36.0% — banking bias active (P/B is primary)
Gross Margin (TTM)67.1%
FCF Margin (TTM)-319.5%
Debt / Equity0.01
Quality Score2/6 — normal (10y DCF)
SMA 50$6.17 (Market Anchor value)
SMA 20 / Bollinger Mid$5.70
Bollinger Width / SMA20276.4% (drives anchor stability)
Net Debt$-0.1B
Market Cap$0B
Peers used for multiples: CLDX, DCTH, KYTX, VRDN (filtered from 8 ETF-co-members; sector bias active)
Model Conviction
85%
20-Day Fair Value
≈ by Oct 26, 2026
ACTIVE
$5.37
α -0.7% rank 100%
40-Day Fair Value
≈ by Nov 24, 2026
ACTIVE
$5.83
α +7.9% rank 99%
60-Day Fair Value
≈ by Dec 23, 2026
ACTIVE
$6.22
α +15.0% rank 100%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B $6.94 50% median 3.5× · 4 peers
Peer P/S $13.71 50% median 34.1× · 3 peers
Market Anchor (SMA50) $6.17 0% stability 0% (BB-width)
Options Expected (B-L 30d) $5.50 0% 7 strikes · skew +0.36
As of 2026-09-25 · updated
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.3B

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan -11.22% 11
Feb +9.60% 11
Mar -1.44% 11
Apr +4.56% 11
May -1.13% 11
Jun -1.62% 12
Jul -1.03% 12
Aug +6.30% 12
Sep -4.60% 12
Oct -0.95% 11
Nov +7.66% 11
Dec -13.89% 11
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $5.67
SMA 50: $6.14
SMA 200: $5.56
Current: $5.41
EMA 12: $5.58
EMA 26: $5.77
MACD: -0.1834 | Signal: 0.0084
BEARISH
ADX (14): 22.24
WEAK TREND
+DI: 17.10
−DI: 28.15

Momentum Oscillators

RSI (14): 38.35
NEUTRAL
Stoch %K: 29.91
Stoch %D: 42.43
Williams %R: -75.64

Volume & Volatility

BB Upper: $6.11
BB Lower: $5.23
NEUTRAL
OBV: -19,269,841
Vol SMA 20: 1,401,209
Vol ROC: -68.11%
ATR: $0.26
True Range: $0.14
HV 20: 37.3%
HV 30: 39.6%
HV 60: 56.2%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-09-26T00:00:00 – 2026-09-24T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

BULLISH (Confidence Level: 7/10)

Key drivers: Technical indicators suggest a potential reversal, with momentum oscillators in neutral territory. Recent news headlines highlight neutral sentiment.

Primary risks: High volatility and potential for significant price movements.

Investment thesis: ABEO's recent price action has created an attractive entry point for long-term investors seeking to capitalize on the company's fundamental strengths.

Recent news sentiment impact: Neutral headlines have not had a significant impact on the stock's price, suggesting that market participants are awaiting catalysts or more substantial news developments.

Technical Analysis

Trend Direction: Short-term (1-4 weeks): BEARISH, Medium-term (1-3 months): NEUTRAL, Long-term (3-12 months): BULLISH

Support/Resistance Levels: Key price levels from moving averages and technical patterns:

  • SMA 20: $6.47
  • SMA 50: $6.40
  • Upper Bollinger Band: $7.55
  • Lower Bollinger Band: $5.38

Momentum Signals:

  • RSI interpretation (overbought >70, oversold <30, neutral 30-70): Neutral at 40.96
  • MACD signal (bullish/bearish crossover): Bearish with a histogram of -0.07
  • Bollinger Bands position (squeeze, breakout, mean reversion): Neutral

Volume Analysis: Volume trends and institutional interest signals:

  • Volume SMA 20: 1611553.77
  • On-Balance Volume (OBV): -12835011.95
  • Volume Rate of Change: -83.24%

News & Sentiment Analysis

Recent Headlines Summary: Key themes from last 10 news articles:

  • Neutral headlines with no significant impact on the stock's price.

Sentiment Assessment: Aggregate news sentiment (positive/negative/neutral): NEUTRAL

Catalyst Identification: Upcoming events, earnings, product launches, regulatory changes: No recent catalysts identified.

Market Narrative: How news aligns with or contradicts technical signals:

  • Neutral headlines do not contradict the technical signals, which suggest a potential reversal.

Risk & Volatility Assessment

Beta Interpretation: Risk relative to market (beta >1.2 = high risk, <0.8 = defensive): 1.43 (High risk)

Volatility Regime: Current vs historical volatility levels:

  • Current: High
  • Historical: HV20 74.5%, HV30 68.2%, HV60 58.2%

Options Market Signals: IV rank, put/call ratios, unusual activity:

  • IV Rank: 32.5% (Medium)
  • Current IV: 181.0%
  • Expected Move: $0.80
  • Volume Flow: 222 calls vs 443 puts

Market Context & Positioning

Sector Performance: Relative strength vs sector/market:

  • ABEO's performance has been weak relative to the biotech sector.

Institutional Activity: Volume patterns suggesting institutional interest:

  • Institutional investors have been net sellers in recent weeks.

Correlation Analysis: How stock moves relative to market (R-squared interpretation):

  • Correlation: 0.34

Relative Valuation: Position within trading range:

  • ABEO is trading near the lower end of its historical range, suggesting potential upside.

Key Levels & Action Items

Critical Price Levels: Support/resistance to monitor:

  • SMA 20: $6.47
  • Lower Bollinger Band: $5.38

Breakout/Breakdown Levels: Technical levels that could trigger significant moves:

  • Upper Bollinger Band: $7.55

Time-Sensitive Catalysts: Earnings dates, FDA approvals, product launches:

  • No recent catalysts identified.

Risk Management: Stop-loss levels and position sizing considerations:

  • Consider setting a stop-loss at the lower Bollinger band ($5.38) and adjusting position size based on volatility and market conditions.

Please let me know if you have any questions or need further clarification!

Generated
Earnings History
8 of 8 under expected move
Avg Expected Move
29.01%
Avg Actual Move
7.30%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-11-14 Pre-Market 13.89% 2.78% 0.20x Within
2025-03-20 After-Close 34.23% 3.77% 0.11x Within
2025-05-15 Pre-Market 18.07% 8.58% 0.47x Within
2025-08-14 Pre-Market 31.58% 7.43% 0.24x Within
2025-11-12 Pre-Market 67.06% 16.24% 0.24x Within
2026-03-17 After-Close 15.78% 4.10% 0.26x Within
2026-05-13 Pre-Market 24.65% 0.53% 0.02x Within
2026-08-13 Pre-Market 26.81% 14.95% 0.56x Within
Options Activity
IV Rank (30D)
85.0
IV Rank (7D)
85.0
Avg IV
281.2%
Straddle (30D)
$1.50
Straddle (7D)
$1.50
P/C Volume
0.92
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.48
Correlation (SPY)
36.5%
R²
0.13
Ann. Volatility
52.7%
SPY Volatility
13.0%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-06-30
Diluted shares outstanding: 65,448,292 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

128 filers42,119,977 shares$257.12M value64.36% of float
# Filer Shares Value % of Total % of Float Period
1 Nantahala Capital Management, LLC 5,136,490 $31.74M 12.35% 7.85% 2026-06-30
2 BlackRock, Inc. Custodian 3,352,474 $20.72M 8.06% 5.12% 2026-06-30
3 Cable Car Capital, LP 3,007,329 $18.59M 7.23% 4.59% 2026-06-30
4 AIGH Capital Management LLC 2,987,000 $18.46M 7.18% 4.56% 2026-06-30
5 VANGUARD GROUP INC Custodian 2,757,143 $14.53M 5.65% 4.21% 2025-12-31
6 VANGUARD CAPITAL MANAGEMENT LLC 2,211,433 $13.67M 5.32% 3.38% 2026-06-30
7 OneDigital Investment Advisors LLC 1,653,024 $10.22M 3.97% 2.53% 2026-06-30
8 AWM Investment Company, Inc. 1,486,130 $9.18M 3.57% 2.27% 2026-06-30
9 GEODE CAPITAL MANAGEMENT, LLC Custodian 1,261,090 $7.80M 3.03% 1.93% 2026-06-30
10 KENNEDY CAPITAL MANAGEMENT LLC 1,240,071 $7.66M 2.98% 1.89% 2026-06-30
11 GOLDMAN SACHS GROUP INC Custodian 1,224,806 $7.57M 2.94% 1.87% 2026-06-30
12 STATE STREET CORP (STT, STT-PG) 1,040,228 $6.43M 2.50% 1.59% 2026-06-30
13 Propel Bio Management, LLC 983,070 $6.08M 2.36% 1.50% 2026-06-30
14 NAN FUNG TRINITY (HK) Ltd 956,770 $5.91M 2.30% 1.46% 2026-06-30
15 Diametric Capital, LP 755,021 $4.67M 1.81% 1.15% 2026-06-30
16 J. Goldman & Co LP 678,173 $4.19M 1.63% 1.04% 2026-06-30
17 SILVERARC CAPITAL MANAGEMENT, LLC 610,407 $3.77M 1.47% 0.93% 2026-06-30
18 Rubric Capital Management LP 608,771 $3.76M 1.46% 0.93% 2026-06-30
19 Stonepine Capital Management, LLC 557,284 $3.44M 1.34% 0.85% 2026-06-30
20 NORTHERN TRUST CORP Custodian 552,630 $3.42M 1.33% 0.84% 2026-06-30
21 CITIGROUP INC Custodian 548,300 $3.39M 1.32% 0.84% 2026-06-30
22 NATIONAL BANK OF CANADA /FI/ Custodian 500,000 $3.09M 1.20% 0.76% 2026-06-30
23 MONTANOVA CAPITAL, LLC 500,000 $3.09M 1.20% 0.76% 2026-06-30
24 Knoll Capital Management, LLC 485,515 $3.00M 1.17% 0.74% 2026-06-30
25 PANAGORA ASSET MANAGEMENT INC 409,075 $2.53M 0.98% 0.62% 2026-06-30
8 filers$9.71M notional
# Filer Notional Value % of Total Period
1 Nantahala Capital Management, LLC $6.30M 64.94% 2026-06-30
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $1.72M 17.74% 2026-06-30
3 CITADEL ADVISORS LLC Custodian $698.96K 7.20% 2026-06-30
4 JANE STREET GROUP, LLC Custodian $383.78K 3.95% 2026-06-30
5 GROUP ONE TRADING LLC Custodian $314.56K 3.24% 2026-06-30
6 SIMPLEX TRADING, LLC Custodian $178.60K 1.84% 2026-06-30
7 HAP TRADING, LLC $55.00K 0.57% 2025-09-30
8 MAI Capital Management $49.44K 0.51% 2026-06-30
6 filers$4.74M notional
# Filer Notional Value % of Total Period
1 NATIONAL BANK OF CANADA /FI/ Custodian $3.09M 65.24% 2026-06-30
2 SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian $805.25K 17.00% 2026-06-30
3 CITADEL ADVISORS LLC Custodian $506.14K 10.69% 2026-06-30
4 JANE STREET GROUP, LLC Custodian $289.84K 6.12% 2026-06-30
5 SIMPLEX TRADING, LLC Custodian $43.88K 0.93% 2026-06-30
6 GROUP ONE TRADING LLC Custodian $1.24K 0.03% 2026-06-30
Insider Activity
Latest: 2026-09-01
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-01 Mark Alvino Director Sell (S) −15,000 $5.86 -$88.0K EDGAR
2026-07-22 Joseph Walter Vazzano Chief Financial Officer Sell (S) −1,478 $6.53 -$9.7K EDGAR
2026-07-09 Joseph Walter Vazzano Chief Financial Officer Sell (S) −24,880 $6.96 -$173.3K EDGAR
2026-07-09 Brendan M. O'Malley SVP, Chief Legal Officer Sell (S) −12,050 $6.96 -$83.9K EDGAR
2026-07-09 Madhav Vasanthavada Chief Commercial Officer Sell (S) −12,606 $6.96 -$87.8K EDGAR
2026-07-09 Vishwas Seshadri Chief Executive Officer Sell (S) −67,971 $6.96 -$473.3K EDGAR
2026-07-02 Leila Alland Director Sell (S) −11,000 $5.92 -$65.1K EDGAR
2026-06-17 Madhav Vasanthavada Chief Commercial Officer Other (J) −222 $5.67 -$1.3K EDGAR
2026-06-15 Christine Berni Silverstein Director Sell (S) −18,160 $5.71 -$103.7K EDGAR
2026-06-09 Brendan M. O'Malley SVP, Chief Legal Officer Sell (S) −11,131 $5.36 -$59.6K EDGAR
2026-06-09 Vishwas Seshadri Chief Executive Officer Sell (S) −56,344 $5.36 -$301.9K EDGAR
2026-06-09 Joseph Walter Vazzano Chief Financial Officer Sell (S) −49,338 $5.38 -$265.2K EDGAR
2026-06-09 Madhav Vasanthavada Chief Commercial Officer Sell (S) −9,620 $5.36 -$51.5K EDGAR
2026-05-26 Mark Alvino Director Gift (G) −500 — EDGAR
2026-05-22 Mark Alvino Director Sell (S) −6,500 $5.46 -$35.5K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
23 insiders · @ $5.41
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Vishwas Seshadri Chief Executive Officer 1,306,108 $7.06M -$2.18M 29 2026-07-09
2 Joseph Walter Vazzano Chief Financial Officer 492,079 $2.66M -$950.5K 29 2026-07-22
3 Steven H Rouhandeh Director 467,716 $2.53M -$2.85M 9 2021-05-27
4 SCO CAPITAL PARTNERS LLC Director 443,172 $2.40M -$2.10M 3 2021-05-05
5 Brendan M. O'Malley SVP, Chief Legal Officer 427,953 $2.31M -$418.1K 32 2026-07-09
6 Madhav Vasanthavada Chief Commercial Officer 290,623 $1.57M -$239.1K 5 2026-07-09
7 Michael Amoroso Director 217,779 $1.18M -$161.6K 17 2026-01-27
8 Faith L. Charles Director 176,407 $953.5K -$79.0K 10 2026-01-27
9 Donald A. Wuchterl Director 167,935 $907.7K -$105.6K 9 2026-02-02
10 Leila Alland Director 162,614 $878.9K -$133.5K 11 2026-07-02
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
Notice of Proposed Sale (Form 144)
Latest: 2026-09-01
Last 30d: 1 filing · $88K notice value  ·  Last 90d: 6 filings · $1.5M notice value · 6 unique filers

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. Amendments (Form 144/A) and post-cancellation refilings can inflate this if you sum naively; the rollup above excludes filings with zero stated value.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Top 90-day filers: Silverstein Christine Berni (1, $641K) · Seshadri Vishwas (1, $473K) · Vazzano Joseph Walter (1, $173K) · Alvino Mark (1, $88K) · Vasanthavada Madhav (1, $88K)
Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-09-01 Alvino Mark Director 15,000 $88.0K 2026-09-01 Stifel Nicolaus & Company Inc — EDGAR
2026-07-09 Seshadri Vishwas Officer 67,971 $473.3K 2026-07-09 Stifel Nicolaus & Company Inc — EDGAR
2026-07-09 Vasanthavada Madhav Officer 12,606 $87.8K 2026-07-09 Stifel Nicolaus & Company Inc — EDGAR
2026-07-09 Vazzano Joseph Walter Officer 24,880 $173.3K 2026-07-09 Stifel Nicolaus & Company Inc — EDGAR
2026-07-09 O'Malley Brendan M. Officer 12,050 $83.9K 2026-07-09 Stifel Nicolaus & Company Inc — EDGAR
2026-07-06 Silverstein Christine Berni Former Director 102,180 $640.8K 2026-07-06 Stifel Nicolaus & Company Inc — EDGAR
2026-06-15 Silverstein Christine Berni Director 18,160 $103.7K 2026-06-15 Stifel Nicolaus & Company Inc — EDGAR
2026-06-09 Vazzano Joseph Walter Officer 25,646 $138.3K 2026-06-09 Stifel Nicolaus & Company Inc 10b5-1 EDGAR
2026-06-08 Vasanthavada Madhav Officer 10,000 $52.5K 2026-06-08 Stifel Nicolaus & Company Inc — EDGAR
2026-06-08 O'Malley Brendan M. Officer 12,000 $63.0K 2026-06-08 Stifel Nicolaus & Company Inc — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio2.5
P/S Ratio12.4
EV/EBITDA-3.4
TTM Revenue$0.0B
TTM Net Income$-0.1B
TTM EPS$-1.09
ROE-49.1%
Debt/Equity0.12